Covid mRNA Shots May Supercharge Cancer Therapies, Study Finds

The same Nobel-winning mRNA technology that helped curb the Covid-19 pandemic may be poised to transform cancer care.

Patients with advanced lung or skin cancer who received a Covid-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who didn’t, researchers at the University of Florida and the University of Texas MD Anderson Cancer Center reported in a study in the journal Nature.

Their review of more than 1,000 medical records at MD Anderson in Houston found that vaccinated patients with non-small cell lung cancer survived a median of 37 months, almost twice as ...